Description
Book SynopsisAddresses a topic of recognized policy concern. This report summarizes a major conference that reviewed our nation's R&D support for biotechnology and information technologies. It emphasizes the fall off in R&D investments needed to sustain the growth of the US economy and to capitalize on the growing investment in biomedicine.
Table of Contents1 Front Matter; 2 Preface; 3 Executive Summary; 4 I. Introduction and Overview; 5 II. Issues in Biotechnology and Information Technology; 6 III. Findings and Recommendations; 7 IV. Proceedings; 8 Welcome; 9 Introduction; 10 Opening Remarks; 11 Panel I: Biotechnology and Information Technologies: The Need for a Diversified Federal Research Portfolio; 12 Panel II: A Historical Perspective: Federal Partnerships in Computing and Biotechnology; 13 Panel III: Biotechnology: Needs and Opportunities; 14 Panel IV: Information Technology: New Opportunities-New Needs; 15 Panel V: Capturing New Opportunities; 16 Panel VI: Intellectual Property and the Public Domain: Sectoral Perspectives; 17 Concluding Remarks; 18 V. Research Papers; 19 The Federal Partnership with U.S. Industry in U.S. Computer Research: History and Recent Concerns; 20 Public Research, Patents, and Implications for Industrial R&D in the Drug, Biotechnology, Semiconductor and Computer Industries; 21 Bioinformatics: Emerging Opportunities and Emerging Gaps; 22 Recent Trends in the Federal Funding of Research and Development Related to Health and Information Technology; 23 Appendix Tables; 24 VI. Annex
